Handelsavisen
prelaunch
Companies Financials ICIR.NS
IC
ICIR.NS NSE (India) Life & Health Insurance

ICICI Prudential Life Insurance Company Ltd

$522,90
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,16 %
Op margin
ROE
2,0 %
Net margin
Debt / equity
0,11
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

ICICI Prudential Life Insurance Company Ltd provides life and health insurance products in India, generating revenue primarily through premium income and investment returns on its insurance reserves.

Business. ICICI Prudential Life Insurance Company Ltd (ICIR.NS) is a life and health insurance provider headquartered in India. The company operates within the Financials sector, specifically the Life & Health Insurance industry, generating revenue primarily through premium income. It is listed on the National Stock Exchange of India (NSE). Specific details regarding operating segments and geographic revenue mix are not available.

Classification92 %
SectorFinancials
Business sectorInsurance
IndustryLife & Health Insurance
Generated · model-assisted
Sell-side consensus
BUY35 analysts
28 buy7 hold0 sell
Avg 12m price target695,76

Analyst recommendations

35 analysts · consensus Buy
Buy28
Hold7
Sell0
12-month price target
695,76
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
35 analysts · indicative
Ownership
not yet wired
Profitability
2,0 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning ICIR.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials · THIS SECTOR−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to ICIR.NS. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    ICICI Prudential Life Insurance Company Ltd (ICIR.NS) is a life and health insurance provider headquartered in India. The company operates within the Financials sector, specifically the Life & Health Insurance industry, generating revenue primarily through premium income. It is listed on the National Stock Exchange of India (NSE). Specific details regarding operating segments and geographic revenue mix are not available.

    Classification92 %
    SectorFinancials
    Business sectorInsurance
    IndustryLife & Health Insurance
    AI synthesis
    GENERATED

    The company maintains a conservative capital structure with a debt-to-equity ratio of 0.11, indicating minimal leverage and a strong equity base. Total equity stands at INR 112.86 billion, while long-term debt is INR 12.00 billion. However, the risk assessment notes that net cash is negative after subtracting total debt, signaling potential liquidity constraints. The liquidity risk is rated as medium, suggesting that while the company is not in immediate distress, it may face challenges in meeting short-term obligations without external financing.

    Profitability metrics show a return on equity (ROE) of 1.99% and a return on assets (ROA) of 0.07%, both of which are below the industry median for life and health insurers. This suggests that the company is underperforming in terms of capital efficiency and asset utilization compared to its peers. The operating income of INR 2.12 billion and net income of INR 2.24 billion reflect modest earnings, which may be constrained by competitive pricing pressures and regulatory costs in the Indian insurance market.

    The company's revenue is concentrated in India, with no material exposure to international markets. This geographic concentration increases vulnerability to domestic economic and regulatory shifts, such as changes in insurance regulations or macroeconomic downturns. The company does not disclose segment-level revenue, but as a life and health insurer, it likely operates in a single business line focused on retail insurance products.

    Looking ahead, the company is expected to maintain a stable revenue trajectory, with no significant growth or contraction projected in the current or next fiscal year. The absence of a clear growth driver, such as expansion into new markets or product lines, suggests that the company is in a mature phase of its business cycle. Analysts have assigned a mean price target of INR 695.76, with a median of INR 693.50, indicating a neutral to slightly bullish outlook.

    The risk assessment highlights a low dilution potential, with no immediate pressure from share issuance or convertible debt. The company's diluted and basic share counts are identical, suggesting no near-term dilution from stock options or warrants. However, the risk of dilution could increase if the company issues additional shares to fund growth initiatives or refinance debt. The company has not disclosed any recent material events, such as mergers, acquisitions, or regulatory actions, that would significantly impact its operations or valuation.

    Key takeaways
    • The company maintains a low debt-to-equity ratio of 0.11, indicating a conservative capital structure.
    • Return on equity (1.99%) and return on assets (0.07%) are below industry medians, suggesting underperformance in capital efficiency.
    • Revenue is concentrated in India, increasing exposure to domestic economic and regulatory risks.
    • Analysts project a neutral to slightly bullish outlook, with a mean price target of INR 695.76.
    • The company faces medium liquidity risk due to negative net cash after subtracting total debt.
    • Dilution risk is currently low, with no immediate pressure from share issuance.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-04-14
    Q1 2026 · Quarter highlights

    Operating income +11,0% YoY; Net income +61,9% YoY.

    Revenue
    Operating incomeINR 6.41B+11,0 % YoY
    Net incomeINR 6.24B+61,9 % YoY
    Free cash flow
    EPS
    Operating cash flow-INR 53.55B+43,1 % YoY
    Financials
    Income statement
    Revenue
    Gross profit
    Operating incomeINR 6.41B
    Net incomeINR 6.24B
    Balance sheet
    Total assetsINR 3.20T
    Total liabilitiesINR 3.06T
    Total equityINR 136.31B
    Cash & equivalents
    Long-term debtINR 25.95B
    Cash flow
    Operating cash flow-INR 53.55B
    CapEx-INR 1.23B
    Free cash flow
    SBC
    Highlights
    • Operating income +11,0% YoY
    • Net income +61,9% YoY

    Valuation TTM

    Market price
    $522,90
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $112.86B
    Net cash
    -$12.00B
    Current ratio
    Debt / equity
    0.1
    ROA
    0.1%
    ROE
    2.0%
    Cash conversion
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    11,52
    Predicted surprise
    -0,01
    Beat probability
    45 %
    Analysts
    35
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-06 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate11,52
    Revenueno estimateno estimate560,3B INR
    Operating incomeno estimateno estimate19,2B INR
    Full-year consensus mean (period as reported by source) · consensus in INR. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution35 analysts
    Strong buy13
    Buy15
    Hold7
    Sell0
    Strong sell0
    12-month price target$695,76 · Median $693,50
    Low $590,00High $885,00
    Operating income · consensus19,2B INR
    EPS surprise
    −5,0 %
    reported vs consensus · miss
    Revenue surprise
    −8,4 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$590,00
    Mean$695,76
    Median$693,50
    High$885,00
    Spot$522,90
    +33.1 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    ROE2,0 %Bottom quartile
    D/E0,11Above median

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Return On Assets
      net_income / total_assets
    Source documents
    • ICICI Prudential Life Insurance Company Ltd Market data — financials · 2026-05-28
    • ICICI Prudential Life Insurance Company Ltd Market data — analyst estimates · 2026-05-28

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    ICIR.NSCanonical
    NSE (India) · USD

    Intel & risk

    PredictorBeat prob45 %Surprise-0,01Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-04-14 14:56 UTCEARNINGSQuarterly results — Q1 2026 Net INR 6.24B
    2026-04-14 14:56 UTCEARNINGSAnnual results — FY 2026 Net INR 16.08B
    2026-01-13 13:39 UTCEARNINGSQuarterly results — Q4 2025 Net INR 3.87B
    2025-10-14 13:50 UTCEARNINGSQuarterly results — Q3 2025 Net INR 2.96B
    2025-07-15 13:44 UTCEARNINGSQuarterly results — Q2 2025 Net INR 3.01B
    2025-04-15 17:01 UTCEARNINGSQuarterly results — Q1 2025 Net INR 3.85B
    2025-04-15 17:01 UTCEARNINGSAnnual results — FY 2025 Net INR 11.86B
    2025-01-21 18:20 UTCEARNINGSQuarterly results — Q4 2024 Net INR 3.25B
    2024-10-22 18:13 UTCEARNINGSQuarterly results — Q3 2024 Net INR 2.51B
    2024-07-23 18:27 UTCEARNINGSQuarterly results — Q2 2024 Net INR 2.24B
    2024-04-23 18:05 UTCEARNINGSAnnual results — FY 2024 Net INR 8.51B
    2023-04-20 18:41 UTCEARNINGSAnnual results — FY 2023 Net INR 8.13B
    2022-04-16 18:06 UTCEARNINGSAnnual results — FY 2022 Net INR 7.59B
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage